Vertex Pharmaceuticals (VRTX) Income from Discontinued Operations (2013 - 2014)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Income from Discontinued Operations (2013 - 2014) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | -209,000.00 |
| Sep 30, 2014 | -64,000.00 |
| Jun 30, 2014 | -293,000.00 |
| Mar 31, 2014 | -346,000.00 |
| Dec 31, 2013 | -163.63 Mn |
| Sep 30, 2013 | -7.21 Mn |
| Jun 30, 2013 | -7.36 Mn |
| Mar 31, 2013 | -5.73 Mn |